Efficacy and Safety of Sofosbuvir-Velpatasvir combination in Hepatitis C Virus-infected Pakistani Patients without Cirrhosis or with Compensated Cirrhosis: A Prospective, Open-label Interventional Trial

Background In Pakistan, there is a paucity of published clinical data regarding the efficacy of sofosbuvir-velpatasvir in the management of patients with hepatitis C without cirrhosis or with compensated cirrhosis. Methods A prospective, open-label, multicenter, interventional trial was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Nazish, Muhammad, Iltaf, Abou Bakr, Attique, Akhtar, Zaheer, Ali, Mashhood, Syed Muhammad, Sharib, Maheshwary, Neeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996271/
https://www.ncbi.nlm.nih.gov/pubmed/32042516
http://dx.doi.org/10.7759/cureus.6537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996271/
https://www.ncbi.nlm.nih.gov/pubmed/32042516
http://dx.doi.org/10.7759/cureus.6537

Ejemplares similares